Remarkable micro exploration of human destiny

In August 2024, he joined Shanghai Lishan Biomedicine Co., LTD

He graduated from the Chinese Academy of Sciences, majoring in Biochemistry and Molecular biology

His main research field is the transcriptional mediator Med23 subunit alleviating inflammatory bowel disease through regulation of oxidative stress, and he led the national Fund key project to study the regulatory functions and fundamentals of small intestinal stem cells.